secwatch.observer — SEC 8-K summary
======================================

Issuer:     Propanc Biopharma, Inc. (PPCB)
CIK:        0001517681
Form:       8-K
Filed at:   2022-09-27T23:59:59+00:00
Accession:  0001493152-22-026871
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Propanc Biopharma issues $71,500 convertible note to GS Capital
---------------------------------------------------------------

- Principal $71,500 with $4,000 OID; net proceeds $67,500 for general working capital.
- Note bears 8% interest; convertible at $0.002/share (fixed) or $0.0009 if stock below $0.0014 for 5 days.
- Maturity March 21, 2023; prepayment premiums of 110%-130% depending on timing.
- Default conversion price at 65% of lowest trading price over 10 days; default interest 24% per annum.
- GS Capital paid $2,500 legal fees; conversion limited to 4.99% beneficial ownership.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1517681/000149315222026871/0001493152-22-026871-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1517681/000149315222026871/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-026871

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer